How much did Epalex raise?

Epalex raised $4.26 Million in a Seed round on October 4, 2022.

Who are the decision-makers at Epalex?

Fundz holds 1 contact at Epalex, including the Director. Names and contact details are shown to Fundz members.

Epalex reported raising $4.26 Million in an initial SEC Form D filing, from an offering of $8.5 Million

PRIVATEOct 14, 2022$4.3M of $8.5M raised

Amount Raised

$4.26 Million

$4.26 Million sold, per SEC Form D (first sale Oct 4, 2022)

Round Type

Seed

Mountain ViewHealthcareHealth Care

Quick answer

Epalex raised $4.26 Million in a Seed round, dated October 4, 2022. Epalex is based in Mountain View, California, United States.

How much did Epalex raise?: Epalex raised $4.26 Million in a Seed round on October 4, 2022.
What does Epalex do?: EpaleX is developing a novel inhaled treatment for epilepsy and migraine.
Where is Epalex based and how big is it?: Epalex is based in Mountain View, California, United States.
Who are the decision-makers at Epalex?: Fundz holds 1 contact at Epalex, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Epalex that raised within 45 days of this round, from Fundz verified event records.

Streamex Corp. raised $1.5M (Seed) on November 18, 2022.
Venus Concept Inc. raised $6.7M on November 18, 2022.
SCA Health raised $18K (Pre-Seed) on November 18, 2022.
Tellus Therapeutics raised $16M on November 17, 2022.
Parabilis Medicines raised $178M on November 17, 2022.
Phio Pharmaceuticals raised $2K (Seed) on November 16, 2022.

Who to call at Epalex, and when

A new round usually means Epalex is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Epalex raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Epalex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Epalex. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Epalex

Location

1049 EL MONTE AVENUE, SUITE C 585

Mountain View, California, United States

About

EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful antiseizure medication that rapidly enters the brain and stops the seizure. The effect of the drug dissipates within minutes, allowing the patient to resume normal daily activity. The inhaler is also used to stop migraine attacks that are refractory to currently available migraine treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Epalex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contactsRandall M., Director hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Epalex's next move

See what Strategic adds

Epalex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.